Stay updated with breaking news from Hilda pickett. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dogma-challenging telomere findings may offer new insights for cancer treatments phys.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phys.org Daily Mail and Mail on Sunday newspapers.
New Telomere Findings May Revolutionize Cancer Treatments miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Dogma-challenging telomere findings may offer eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
New compound could lead to therapeutics that selectively kill cancer cells phys.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phys.org Daily Mail and Mail on Sunday newspapers.
Tessellate BIO, an Emerging Precision Oncology Company, Announces the Appointment of World-Leading Scientists to its Scientific Advisory Board tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
The company aims to become a global leader in precision oncology by redefining Synthetic Lethality to treat large, currently unserved patient populationsLead program targets Alternative Lengthening of Telomeres (ALT)
Tessellate BIO Emerges from Stealth tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Genomics Health Futures Mission Professor Anne Cust, Deputy Director of the Daffodil Centre, was awarded $3 million to deliver improved practice and policy-relevant genomic risk prediction and increase the effectiveness of cancer screening and early detection services for the four most common cancers in Australia –breast, prostate, melanoma and colorectal cancers. Working directly with consumers, health professionals and policy stakeholders, the team aim to reduce the cancer burden and help Australians live longer and healthier lives. Childhood Cancer Research Associate Professor Hilda Pickett was awarded $1.4 million for her project Alternative Lengthening of Telomeres (ALT): Target discovery to treatment. Osteosarcoma is the most common type of primary bone malignancy, with the highest incidence in adolescence. Survival has shown little improvement over the last three decades. The majority of osteosarcomas activate the ALT pathway. The team have discovered a weakness of ALT cells that they aim to exploit through the development of chemical inhibitors that are rapidly toxic to ALT cells. This approach will offer improved treatments for adolescent osteosarcomas.
Date Time Researchers awarded $22 million for medical research The University of Sydney has received funding for 14 projects from the Medical Research Future Fund (MRFF) to improve health outcomes for Australians. The Minister for Health and Aged Care, the Hon Greg Hunt, has announced $180 million in funding for 105 medical research projects, to improve health outcomes for Australians. Deputy Vice-Chancellor (Research), Professor Duncan Ivison welcomed the funding announcement which awarded $22.3 million to the University of Sydney for 14 projects. “The funding of these 14 projects will support the important work our researchers do in improving the lives of Australians – from screening and early detection for common cancers to evaluating novel drugs for stroke patients.”